I spoke to one of the world's leading orthopods, probably #1 or #2. He saw BONE last year and was very impressed. He spent a lot of time at their booth this year and was blown away this time. He believes BONE has a opportunity to screw it up or control their destiny to the top of the industry. He has used their products, and has switched exclusively to them, and what he sees now is out of sight.
I used to own a ton of BONE close to 5%, sold a lot and am buying it all back. My bet is that it is sold at 6-7X 2013 revs of $75m +++.
I used to own a ton of BONE close to 5%, sold a lot and am buying it all back. My bet is that it is sold at 6-7X 2013 revs of $75m +++.
Recent XTNT News
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 05/13/2026 11:33:08 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 11:15:38 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 11:05:34 AM
- Xtant Medical Reports First Quarter 2026 Financial Results • PR Newswire (US) • 05/13/2026 11:00:00 AM
- Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026 • PR Newswire (US) • 05/07/2026 12:00:00 PM
- Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped • PR Newswire (US) • 05/06/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/13/2026 01:20:24 PM
- Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product • PR Newswire (US) • 04/13/2026 01:04:00 PM
- Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial • PR Newswire (US) • 04/09/2026 12:00:00 PM
- Xtant Medical shares drop nearly 5% as weak 2026 outlook overshadows Q4 beat • IH Market News • 03/31/2026 02:54:42 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 11:16:07 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 11:05:23 AM
- Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results • PR Newswire (US) • 03/31/2026 11:00:00 AM
- Xtant Medical to Announce Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026 • PR Newswire (US) • 03/25/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/02/2026 01:15:49 PM
- Xtant Medical Finalizes Companion Spine Transactions • PR Newswire (US) • 03/02/2026 01:00:00 PM
- Xtant Medical to Participate in the Canaccord Genuity 2026 Musculoskeletal Conference • PR Newswire (US) • 02/25/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2026 10:00:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2026 09:15:32 PM
- Xtant Medical Announces Commercial Launch of its Next-Generation nanOss Strata™ Synthetic Bone Graft • PR Newswire (US) • 12/11/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/03/2025 09:05:52 PM
- Xtant Medical Completes Sale of its Coflex® Assets and Paradigm OUS Businesses to Companion Spine • PR Newswire (US) • 12/01/2025 09:05:00 PM
